
Syntis Bio
Developing the next generation of drug delivery systems to enable safe and efficient delivery of therapeutics through the gastrointestinal tract as well as developing novel ingestible electronic devices for sensing a broad array of physiologic and pathophysiologic parameters.
Employees
Enterprise value
$132—198m
Authorizing premium user...